Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.
Among people exposed to the COVID-19 (SARS-COV-2) pandemic, elderly people are considered as particularly vulnerable, especially those living in nursing homes or hospitalized. Furthermore, facilities / accommodations are registered among the main locations of COVID-19 clusters.
These observations have led the French government to establish specific protection measures and survey dependent care facilities for the elderly and long-term care units in the hospital.
With these new standards established, a long-term study of all the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Serology testing, RT PCR | Diagnostic Test | Periodic testings and testings with characteristic symptoms occur |
| Measure | Description | Time Frame |
|---|---|---|
| General prevalence of COVID-19 | measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test | Through the study completion, an average of 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of asymptomatic residents/inpatients |
| Through study completion, an average of 12 months |
| Number of symptomatic residents/inpatients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), from march, 2020, to december, 2021, who are not opposed to participate in this study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shidasp SIAMI, MD, PhD | Contact | 0033 1 60 80 79 40 | ssiami@ch-sudessonne.fr | |
| Delphine LEMAIRE-BRUNEL | Contact | 0033 1 60 80 79 88 | dlemaire-brunel@ch-sudessonne.fr |
| Name | Affiliation | Role |
|---|---|---|
| Shidasp SIAMI, MD, PhD | Centre Hospitalier Sud Essonne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Sud Essonne | Recruiting | Étampes | Essonne | 91150 | France |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Positive RT-PCR test or serologic test with symptoms
| Through study completion, an average of 12 months |
| Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization | Positive RT-PCR test or serologic test and hospitalization | Through study completion, an average of 12 months |
| Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit | Positive RT-PCR test or serologic test and hospitalization in critical care unit | Through study completion, an average of 12 months |
| Number of residents/inpatients infected with COVID-19 and deceased | Positive RT-PCR test or serologic test and deceased | Through study completion, an average of 12 months |
| Number of residents/inpatients vaccinated against COVID-19 | Positive RT-PCR test or serologic test and vaccinated with any authorized vaccine | Through study completion, an average of 12 months |
| Influencing factors of the prevalence of COVID-19 among residents/inpatients |
| Through study completion, an average of 12 months |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |